Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine

by Sun, Weili, Modak, Shakeel
Published 2012

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma

by Modak, Shakeel, Kushner, Brian H., Kramer, Kim, Vickers, Andrew, Cheung, Irene Y., Cheung, Nai-Kong V.
Published 2013

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

by Kushner, Brian H., Ostrovnaya, Irina, Cheung, Irene Y., Kuk, Deborah, Modak, Shakeel, Kramer, Kim, Roberts, Stephen S., Basu, Ellen M., Yataghene, Karima, Cheung, Nai-Kong V.
Published 2015

Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor

by Forlenza, Christopher J., Kushner, Brian H., Kernan, Nancy, Boulad, Farid, Magnan, Heather, Wexler, Leonard, Wolden, Suzanne L., LaQuaglia, Michael P., Modak, Shakeel
Published 2015

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome

by Padovan-Merhar, Olivia M., Raman, Pichai, Ostrovnaya, Irina, Kalletla, Karthik, Rubnitz, Kaitlyn R., Sanford, Eric M., Ali, Siraj M., Miller, Vincent A., Mossé, Yael P., Granger, Meaghan P., Weiss, Brian, Maris, John M., Modak, Shakeel
Published 2016